VAOCLEST Trademark

Trademark Overview

On Wednesday, March 24, 2021, a trademark application was filed for VAOCLEST with the United States Patent and Trademark Office. The USPTO has given the VAOCLEST trademark a serial number of 90599767. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Tuesday, May 28, 2024. This trademark is owned by Pfizer Inc.. The VAOCLEST trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use
vaoclest

General Information

Serial Number90599767
Word MarkVAOCLEST
Filing DateWednesday, March 24, 2021
Status734 - FIFTH EXTENSION - GRANTED
Status DateTuesday, May 28, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 2, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, June 29, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10001-2192
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Tuesday, September 28, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, March 27, 2021NEW APPLICATION ENTERED
Tuesday, June 29, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, September 25, 2021ASSIGNED TO EXAMINER
Tuesday, November 2, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, October 13, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 2, 2021PUBLISHED FOR OPPOSITION
Tuesday, December 28, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, November 28, 2022SOU TEAS EXTENSION RECEIVED
Monday, June 6, 2022SOU TEAS EXTENSION RECEIVED
Monday, June 6, 2022SOU EXTENSION 1 FILED
Monday, June 6, 2022SOU EXTENSION 1 GRANTED
Wednesday, June 8, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 27, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, November 28, 2022SOU EXTENSION 2 FILED
Monday, November 28, 2022SOU EXTENSION 2 GRANTED
Wednesday, November 30, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 27, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, May 3, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, May 3, 2023SOU EXTENSION 3 FILED
Wednesday, May 3, 2023SOU EXTENSION 3 GRANTED
Friday, May 5, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 22, 2023SOU TEAS EXTENSION RECEIVED
Monday, March 27, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 27, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 27, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, November 22, 2023SOU EXTENSION 4 FILED
Wednesday, November 22, 2023SOU EXTENSION 4 GRANTED
Friday, November 24, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 28, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, May 28, 2024SOU EXTENSION 5 GRANTED
Tuesday, May 28, 2024SOU EXTENSION 5 FILED
Wednesday, May 29, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

vaoclest preparations disorders pharmaceutical treatment hypertension pain stroke cancer growth bone